$AEON 8-K SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Regulation FD Disclosure Disrupting a $3.5B neurotoxin market dominated by a single brand for >30 years CORPORATE PRESENTATION / OCTOBER 2026 NYSEAMERICAN: AEON © 2 0 2 6 A E O N B I O P H A R M A
30 Sep 2026	8-K: Regulation FD Disclosure; Other Events FDA indicated previously completed ABP-450 head-to-head studies versus BOTOX® may be submitted as supportive evidence; AEON expects to advance the required scientific bridging work
12 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
03 Aug 2026	8-K: Regulation FD Disclosure; Other Events
23 Jul 2026	8-K: Other Events
15 Jul 2026	8-K: Entry into a Material Definitive Agreement; Other Events
17 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
14 May 2026	8-K: Regulation FD Disclosure
14 May 2026	8-K: Results of Operations and Financial Condition
03 Apr 2026	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
30 Mar 2026	8-K: Results of Operations and Financial Condition
09 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
21 Jan 2026	8-K: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation +3 more
12 Jan 2026	8-K: Regulation FD Disclosure
15 Dec 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
04 Dec 2025	8-K: Regulation FD Disclosure
14 Nov 2025	8-K: Results of Operations and Financial Condition
13 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
08 Sep 2025	8-K: Regulation FD Disclosure
12 Aug 2025	8-K: Results of Operations and Financial Condition

Comments